Fractionated Radioimmunotherapy with 90Y-Labeled Fully Human Anti-CEA Antibody
Author:
Affiliation:
1. Gunma University Graduate School of Medicine, Maebashi, Japan.
2. Graduate School of Pharmaceutical Sciences, Chiba University, Chiba, Japan.
3. Faculty of Medicine, Fukuoka University, Fukuoka, Japan.
Publisher
Mary Ann Liebert Inc
Subject
Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine,Cancer Research,Pharmacology,Radiology Nuclear Medicine and imaging,Oncology,General Medicine
Link
http://www.liebertpub.com/doi/pdf/10.1089/cbr.2013.1562
Reference32 articles.
1. Long-term responses in patients with recurring or refractory B-cell non-Hodgkin lymphoma treated with yttrium 90 ibritumomab tiuxetan
2. Tositumomab and Iodine-131 Tositumomab Produces Durable Complete Remissions in a Subset of Heavily Pretreated Patients With Low-Grade and Transformed Non-Hodgkin’s Lymphomas
3. Expression of carcinoembryonic antigen (CEA) and nonspecific crossreacting antigen (NCA) in gastrointestinal cancer; the correlation with degree of differentiation
4. The carcinoembryonic antigen (CEA) family: structures, suggested functions and expression in normal and malignant tissues
Cited by 8 articles. 订阅此论文施引文献 订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
1. Comparative evaluation of radionuclide therapy using 90Y and 177Lu;Annals of Nuclear Medicine;2022-11-09
2. Radiolabeled Antibodies for Cancer Radioimmunotherapy;Nuclear Medicine and Immunology;2021-11-25
3. Immuno-PET imaging for non-invasive assessment of cetuximab accumulation in non-small cell lung cancer;BMC Cancer;2019-10-24
4. Pretargeted radioimmunotherapy and SPECT imaging of peritoneal carcinomatosis using bioorthogonal click chemistry: probe selection and first proof-of-concept;Theranostics;2019
5. Circulating FABP4 is eliminated by the kidney via glomerular filtration followed by megalin-mediated reabsorption;Scientific Reports;2018-11-06
1.学者识别学者识别
2.学术分析学术分析
3.人才评估人才评估
"同舟云学术"是以全球学者为主线,采集、加工和组织学术论文而形成的新型学术文献查询和分析系统,可以对全球学者进行文献检索和人才价值评估。用户可以通过关注某些学科领域的顶尖人物而持续追踪该领域的学科进展和研究前沿。经过近期的数据扩容,当前同舟云学术共收录了国内外主流学术期刊6万余种,收集的期刊论文及会议论文总量共计约1.5亿篇,并以每天添加12000余篇中外论文的速度递增。我们也可以为用户提供个性化、定制化的学者数据。欢迎来电咨询!咨询电话:010-8811{复制后删除}0370
www.globalauthorid.com
TOP
Copyright © 2019-2024 北京同舟云网络信息技术有限公司 京公网安备11010802033243号 京ICP备18003416号-3